ADR reports referring to “off-label use” (3.5%, n = 722*) | |
---|---|
The five drug substances most frequently reported a | |
1. | aripiprazole (5.0%; 36/722) |
2. | levetiracetam (3.0%; 22/722) |
3. | methylphenidate (2.6%; 19/722) |
4. | eculizumab (2.2%; 16/722) |
5. | valproinic acid (2.2%; 16/722) |
The five ADRs most frequently reported (except PTs coding for off-label use) a | |
1. | drug ineffective (4.0%; 29/722) |
2. | seizure (3.9%; 28/722) |
3. | fatigue (3.7%; 27/722) |
4. | vomiting (3.5%; 25/722) |
5. | nausea (2.9%; 21/722) |